CONFORMATIONAL CHANGE IN HUMAN DNA REPAIR ENZYME O-6-METHYLGUANINE-DNA METHYLTRANSFERASE UPON ALKYLATION OF ITS ACTIVE SITE BY SN1 (INDIRECT-ACTING) AND SN2 (DIRECT-ACTING) ALKYLATING AGENTS - BREAKING A SALT-LINK

摘要

Human O-6-methylguanine-DNA methyltransferase (MGMT) repairs DNA by transferring alkyl (R-) adducts from O-6-alkylguanine (6RG) in DNA to its own cysteine residue at codon 145 (formation of R-MGMT). We show here that R-MGMT in cell extracts, which is sensitive to protease V8 cleavage at the glutamic acid residues at codons 30 (E30) and 172 (E172), can be specifically immunoprecipitated with an MGMT monoclonal antibody, Mab.3C7. This Mab recognizes an epitope of human MGMT including the lysine 107 (K107) which is within the most basic region that is highly conserved among mammalian MGMTs, Surprisingly, the K107L mutant protein is repair-deficient and readily cleaved by protease V8 similar to R-MGMT. We propose thai R-MGMT adopted an altered conformation which exposed the Mab.3C7 epitope and rendered the protein sensitive to protease V8 attack. This proposal could be explained by the disruption of a structural ''salt-link'' within the molecule based on the available structural and biochemical data. The specific binding of Mab.3C7 to R-MGMT has been compared with the protease V8 method in the detection of R-MGMT in extracts of cells treated with low dosages of methyliodide (SN2) and O-6-benzylguanine. Their identical behaviors in producing protease V8 sensitive R-MGMT and Mab.3C7 immunoprecipitates suggest that probably methyl iodide (an ineffective agent in producing 6RG in DNA) can directly alkylate the active site of cellular MGMT similar to O-6-benzylguanine, The effectiveness of Mel in producing R-MGMT, i.e, inactivation of cellular MGMT, indicates that this agent can increase the effectiveness of environmental and endogenously produced alkylating carcinogens in producing the mutagenic O-6-alkylguanine residues in DNA in vivo.